Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Rapid CommunicationShort Communication

Hepatocellular Disposition and Transporter Interactions with Tolvaptan and Metabolites in Sandwich-Cultured Human Hepatocytes

Yang Lu, Jason R. Slizgi, Kenneth R. Brouwer, Robert L. St. Claire, Kimberly M. Freeman, Maxwell Pan, William J. Brock and Kim L. R. Brouwer
Drug Metabolism and Disposition June 2016, 44 (6) 867-870; DOI: https://doi.org/10.1124/dmd.115.067629
Yang Lu
Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina (Y.L., J.R.S., K.L.R.B); Qualyst Transporter Solutions, Durham, North Carolina (K.R.B., R.L.S.C., K.M.F); Otsuka PDC, Inc., Rockville, Maryland (M.P.); Brock Scientific Consulting, Montgomery Village, Maryland (W.J.B.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jason R. Slizgi
Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina (Y.L., J.R.S., K.L.R.B); Qualyst Transporter Solutions, Durham, North Carolina (K.R.B., R.L.S.C., K.M.F); Otsuka PDC, Inc., Rockville, Maryland (M.P.); Brock Scientific Consulting, Montgomery Village, Maryland (W.J.B.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenneth R. Brouwer
Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina (Y.L., J.R.S., K.L.R.B); Qualyst Transporter Solutions, Durham, North Carolina (K.R.B., R.L.S.C., K.M.F); Otsuka PDC, Inc., Rockville, Maryland (M.P.); Brock Scientific Consulting, Montgomery Village, Maryland (W.J.B.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert L. St. Claire
Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina (Y.L., J.R.S., K.L.R.B); Qualyst Transporter Solutions, Durham, North Carolina (K.R.B., R.L.S.C., K.M.F); Otsuka PDC, Inc., Rockville, Maryland (M.P.); Brock Scientific Consulting, Montgomery Village, Maryland (W.J.B.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kimberly M. Freeman
Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina (Y.L., J.R.S., K.L.R.B); Qualyst Transporter Solutions, Durham, North Carolina (K.R.B., R.L.S.C., K.M.F); Otsuka PDC, Inc., Rockville, Maryland (M.P.); Brock Scientific Consulting, Montgomery Village, Maryland (W.J.B.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maxwell Pan
Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina (Y.L., J.R.S., K.L.R.B); Qualyst Transporter Solutions, Durham, North Carolina (K.R.B., R.L.S.C., K.M.F); Otsuka PDC, Inc., Rockville, Maryland (M.P.); Brock Scientific Consulting, Montgomery Village, Maryland (W.J.B.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William J. Brock
Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina (Y.L., J.R.S., K.L.R.B); Qualyst Transporter Solutions, Durham, North Carolina (K.R.B., R.L.S.C., K.M.F); Otsuka PDC, Inc., Rockville, Maryland (M.P.); Brock Scientific Consulting, Montgomery Village, Maryland (W.J.B.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kim L. R. Brouwer
Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina (Y.L., J.R.S., K.L.R.B); Qualyst Transporter Solutions, Durham, North Carolina (K.R.B., R.L.S.C., K.M.F); Otsuka PDC, Inc., Rockville, Maryland (M.P.); Brock Scientific Consulting, Montgomery Village, Maryland (W.J.B.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Article Information

vol. 44 no. 6 867-870
DOI 
https://doi.org/10.1124/dmd.115.067629
PubMed 
27013400

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received October 16, 2105
  • Accepted March 21, 2016
  • Published online May 2, 2016.

Article Versions

  • Earlier version (March 24, 2016 - 06:28).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2016 by The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Yang Lu,
  2. Jason R. Slizgi,
  3. Kenneth R. Brouwer,
  4. Robert L. St. Claire,
  5. Kimberly M. Freeman,
  6. Maxwell Pan,
  7. William J. Brock, and
  8. Kim L. R. Brouwer
  1. Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina (Y.L., J.R.S., K.L.R.B); Qualyst Transporter Solutions, Durham, North Carolina (K.R.B., R.L.S.C., K.M.F); Otsuka PDC, Inc., Rockville, Maryland (M.P.); Brock Scientific Consulting, Montgomery Village, Maryland (W.J.B.)
  1. Address correspondence to:
    Dr. Kim L. R. Brouwer, Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, 301 Pharmacy Lane CB #7569 Kerr Hall, Chapel Hill, NC 27599. E-mail: kbrouwer{at}unc.edu
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2017 to March 2023

AbstractFullPdf
Aug 201752623
Sep 201741814
Oct 201752922
Nov 201743117
Dec 20172238
Jan 201822910
Feb 201811316
Mar 201802517
Apr 201802124
May 201823231
Jun 201812625
Jul 201841413
Aug 20180168
Sep 201831611
Oct 201801410
Nov 20181128
Dec 20181186
Jan 20192165
Feb 201942312
Mar 201941312
Apr 201931817
May 20193139
Jun 201931216
Jul 2019088
Aug 201912012
Oct 201902115
Nov 20193126
Dec 20195195
Jan 202091712
Feb 20205167
Mar 20200195
May 2020399
Jun 20203158
Jul 20200218
Aug 20200169
Sep 20207147
Oct 20204913
Nov 202011010
Dec 202052311
Jan 202142523
Feb 202131513
Mar 20213145
Apr 20218914
May 2021161411
Jun 202126810
Jul 2021291214
Aug 2021271913
Sep 20211168
Oct 202131926
Nov 202121423
Dec 20210119
Jan 2022178
Feb 2022386
Mar 20222287
Apr 202201715
May 20221320
Jun 20222475
Jul 202222219
Aug 20222516
Sep 202212642
Oct 202216830
Nov 202213116
Dec 20223015
Jan 20234924
Feb 20232223
Mar 20231813

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 44 (6)
Drug Metabolism and Disposition
Vol. 44, Issue 6
1 Jun 2016
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Hepatocellular Disposition and Transporter Interactions with Tolvaptan and Metabolites in Sandwich-Cultured Human Hepatocytes
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Rapid CommunicationShort Communication

Tolvaptan Disposition and DDIs in SCHH

Yang Lu, Jason R. Slizgi, Kenneth R. Brouwer, Robert L. St. Claire, Kimberly M. Freeman, Maxwell Pan, William J. Brock and Kim L. R. Brouwer
Drug Metabolism and Disposition June 1, 2016, 44 (6) 867-870; DOI: https://doi.org/10.1124/dmd.115.067629

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Rapid CommunicationShort Communication

Tolvaptan Disposition and DDIs in SCHH

Yang Lu, Jason R. Slizgi, Kenneth R. Brouwer, Robert L. St. Claire, Kimberly M. Freeman, Maxwell Pan, William J. Brock and Kim L. R. Brouwer
Drug Metabolism and Disposition June 1, 2016, 44 (6) 867-870; DOI: https://doi.org/10.1124/dmd.115.067629
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results and Discussion
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Preincubation Effects on Inhibition of OCT1 by CsA
  • Carbamazepine Metabolite and Hypersensitivity Reactions
  • SULT4A1 Preserves Mitochondrial Function
Show more Short Communication

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics